Insiders · DRMA

DRMA insider transactions

Dermata Therapeutics Inc. (DRMA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for DRMA

• 78d
  SVP, Regulatory Affairs Bedoya-Toro Munera Maria E bought $1,270 worth of shares (1,000 units at $1.27), increasing direct ownership by 8,333% to 1,012 units (SEC Form 4)

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 148d
  SEC Form 4 filed by Director Sandler Andrew Seth

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 148d
  SEC Form 4 filed by Director Wierenga Wendell

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 148d
  SEC Form 4 filed by Senior VP, CDO Nardo Christopher J.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 148d
  SEC Form 4 filed by Director Scott Kathleen D.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 148d
  SEC Form 4 filed by SVP, Regulatory Affairs Bedoya-Toro Munera Maria E

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 148d
  SEC Form 4 filed by Director Hale David F

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 148d
  SEC Form 4 filed by President, CEO and Chairman Proehl Gerald T

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 148d
  SEC Form 4 filed by Director Bradrick Brittany

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 148d
  SEC Form 4 filed by SVP, CFO Van Hoose Kyri K.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 148d
  SEC Form 4 filed by Director Fisher Mary

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 148d
  SEC Form 4 filed by Director Mento Steven J

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 156d
  SVP, CFO Van Hoose Kyri K. was granted 122,549 shares, increasing direct ownership by 1,556% to 130,423 units (SEC Form 4)

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 156d
  PRESIDENT, CHAIRMAN, CEO Proehl Gerald T was granted 612,745 shares (SEC Form 4)

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 496d
  Director Fisher Mary was granted 196,851 shares, increasing direct ownership by 207,212% to 196,946 units (SEC Form 4)

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 496d
  SVP, CFO Van Hoose Kyri K. was granted 78,741 shares (SEC Form 4)

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 496d
  President, CEO and Chairman Proehl Gerald T was granted 787,402 shares (SEC Form 4)

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 496d
  Director Hale David F was granted 78,741 shares (SEC Form 4)

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 505d
  SEC Form 4 filed by Director Sandler Andrew Seth

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 505d
  SEC Form 4 filed by Senior VP, CDO Nardo Christopher J.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 505d
  SEC Form 4 filed by Director Bradrick Brittany

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 505d
  SEC Form 4 filed by SVP, Regulatory Affairs Bedoya-Toro Munera Maria E

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 505d
  SEC Form 4 filed by Director Hale David F

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 505d
  SEC Form 4 filed by Director Wierenga Wendell

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 505d
  SEC Form 4 filed by Director Fisher Mary

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 505d
  SEC Form 4 filed by SVP, CFO Van Hoose Kyri K.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 505d
  SEC Form 4 filed by President, CEO and Chairman Proehl Gerald T

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 505d
  SEC Form 4 filed by Director Mento Steven J

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 505d
  SEC Form 4 filed by Director Scott Kathleen D.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 880d
  SEC Form 4 filed by Mento Steven J

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 880d
  SEC Form 4 filed by Proehl Gerald T

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 880d
  SEC Form 4 filed by Fisher Mary

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 880d
  SEC Form 4 filed by Scott Kathleen D.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 880d
  SEC Form 4 filed by Nardo Christopher J.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 880d
  SEC Form 4 filed by Sandler Andrew Seth

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 880d
  SEC Form 4 filed by Hale David F

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 880d
  SEC Form 4 filed by Wierenga Wendell

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 880d
  SEC Form 4 filed by Bradrick Brittany

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 880d
  SEC Form 4 filed by Van Hoose Kyri K.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 880d
  SEC Form 4 filed by Bedoya-Toro Munera Maria E

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1245d
  SEC Form 4 filed by Van Hoose Kyri K.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1245d
  SEC Form 4 filed by Nardo Christopher J.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1245d
  SEC Form 4 filed by Bedoya-Toro Munera Maria E

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1335d
  SEC Form 4: Sandler Andrew Seth was granted 10,120 shares, increasing direct ownership by 72% to 24,184 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1335d
  SEC Form 4: Bradrick Brittany was granted 9,810 shares, increasing direct ownership by 72% to 23,443 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1335d
  SEC Form 4: Hale David F was granted 30,155 shares, increasing direct ownership by 66% to 75,720 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1335d
  SEC Form 4: Fisher Mary was granted 9,810 shares, increasing direct ownership by 72% to 23,443 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1335d
  SEC Form 4: Scott Kathleen D. was granted 11,359 shares, increasing direct ownership by 72% to 27,145 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1335d
  SEC Form 4: Wierenga Wendell was granted 20,654 shares, increasing direct ownership by 49% to 62,398 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1426d
  SEC Form 4: Bradrick Brittany was granted 8,602 shares, increasing direct ownership by 171% to 13,633 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1426d
  SEC Form 4: Scott Kathleen D. was granted 9,960 shares, increasing direct ownership by 171% to 15,786 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1426d
  SEC Form 4: Sandler Andrew Seth was granted 8,874 shares, increasing direct ownership by 171% to 14,064 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1426d
  SEC Form 4: Hale David F was granted 26,441 shares, increasing direct ownership by 138% to 45,565 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1426d
  SEC Form 4: Fisher Mary was granted 8,602 shares, increasing direct ownership by 171% to 13,633 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1426d
  SEC Form 4: Wierenga Wendell was granted 18,110 shares, increasing direct ownership by 77% to 41,744 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1427d
  SEC Form 4 filed by Nardo Christopher J.

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1517d
  SEC Form 4: Wierenga Wendell was granted 10,593 shares, increasing direct ownership by 217% to 15,471 units

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1517d
  SEC Form 4: Fisher Mary was granted 5,031 shares

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1517d
  SEC Form 4: Scott Kathleen D. was granted 5,826 shares

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)
• 1517d
  SEC Form 4: Sandler Andrew Seth was granted 5,190 shares

  4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)